Department of Health and Human Services
Part 1. Overview Information -- 6 2 2016

 

Participating Organization(s)

Agency for Healthcare Research and Quality (AHRQ)

 NOTE:  The policies, guidelines, terms, and conditions stated in this announcement may differ from those used by the NIH.  Where this Funding Opportunity Announcement (FOA) provides specific written guidance that may differ from the general guidance provided in the grant application form, please follow the instructions given in this FOA. Also note that AHRQ may have different page limits than NIH for the application Research Strategy; if this is the case, page limits are indicated within the individual FOA. AHRQ Grants Policy and Information to applicants regarding Funding Opportunity Announcement procedures can be found at http://www.ahrq.gov/funding/policies/foaguidance/index.html

Components of Participating Organizations

Agency for Healthcare Research and Quality (AHRQ)

Funding Opportunity Title

AHRQ Conference Grant Programs (R13)

Activity Code

R13 Support for Conferences and Scientific Meetings

Announcement Type

This Funding Opportunity Announcement (FOA) is a new Program Announcement.  This FOA supersedes previous AHRQ Conference Grant FOA PA-13-017 (AHRQ Conference Grant Program (R13)

Related Notices
  • September 20, 2017 - Updates to Active Funding Opportunity Announcements to Prepare for Policy Changes Impacting Due Dates On or After January 25, 2018. See NOT-OD-17-114.
  • May 10, 2017 - New AHRQ "FORMS-E" Grant Application Forms and Instructions Coming for Due Dates On or After January 25, 2018. See NOT-HS-17-015.
Funding Opportunity Announcement (FOA) Number

PA-16-453

Note: Applications submitted in response to this Funding Opportunity Announcement (FOA) for Federal assistance must be submitted electronically through Grants.gov using the SF424 Research and Related (R&R) Application Guide.

APPLICATIONS MAY NOT BE SUBMITTED IN PAPER FORMAT

This FOA must be read in conjunction with the application guidelines included with this announcement in http://www.grants.gov/web/grants/applicants/apply-for-grants.html  (hereafter called Grants.gov/Apply).  A registration process is necessary before submission and applicants are highly encouraged to start the process at least six (6) weeks prior to the grant submission date.  See Section IV.

A compatible version of Adobe Reader is required for download. For Assistance downloading this or any Grants.gov application package, please contact Grants.gov Customer Support.

Companion Funding Opportunity

None

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.226    

Funding Opportunity Purpose

 Executive Summary

The Agency for Healthcare Research and Quality (AHRQ) announces its interest in supporting conferences through the AHRQ Single Year and Multiple Year Conference Grant Programs (R13).  AHRQ seeks to support conferences that help to further its mission to produce evidence to make health care safer, higher quality, more accessible, equitable and affordable, and to work with HHS and other partners to make sure that the evidence is understood and used (http://www.ahrq.gov/funding/policies/foaguidance/index.html.

The types of conferences eligible for support include:

1) Research Development - conferences where issues or challenges in the practice and delivery of health care are defined and a research agenda or strategy for studying them is developed;

2) Research design and methodology - conferences where methodological and technical issues of major importance in the field of health services research are addressed or new designs and methodologies are developed;

3) Dissemination and implementation - conferences where research findings and evidence-based information and tools are summarized, communicated and used by organizations and individuals that have the capability to use the information to improve the outcomes, quality, access to, and cost and utilization of health care services; and/or,

4) Research training, infrastructure and career development - conferences where faculty, trainees and students are brought together with stakeholders to develop, share or disseminate research products, experiences, curricula, syllabi, or training competencies.  These types of conferences are not for the training of individuals in health services research.

The applicant must clearly identify which type of conference is being proposed.

AHRQ is especially interested in supporting conferences that demonstrate strategies that include plans for disseminating complementary conference materials and products beyond the participants attending the event.  Regionally-based conferences are acceptable with the expectation that plans will be developed for national dissemination.  Such strategies might include, but are not limited to, submitting articles for publication, posting information on a website, and seeking formal opportunities to discuss conference information with others.  

Key Dates

 

Posted Date

September 29, 2016

Open Date (Earliest Submission Date)

November, 2 2016

Letter of Intent Due Date(s)

A letter of intent is NOT required to apply.

Application Due Date(s)

Application Due Dates: February 1, May 1, August 1, and November 1 annually beginning, February 1, 2017, by 5:00 PM local time of applicant organization), by 5:00 PM local time of applicant organization.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

AIDS Application Due Date(s)

 Not applicable.

Scientific Merit Review

 Generally, four months after receipt date.  

Advisory Council Review

 Not applicable.

Earliest Start Date

Generally, four months after peer review date.

Applicants should plan well ahead to submit an application and allow a minimum of 8 months (from the receipt date to the earliest possible start date. 

Expiration Date

 November 2, 2021.

Due Dates for E.O. 12372

Not Applicable.

Required Application Instructions

It is critical that applicants follow the instructions in the Research Instructions for the SF424 (R&R) Application Guide, except where instructed to do otherwise (in this FOA or in a Notice from the NIH Guide for Grants and Contracts). Conformance to all requirements (both in the Application Guide and the FOA) is required and strictly enforced. Applicants must read and follow all application instructions in the Application Guide as well as any program-specific instructions noted in Section IV. When the program-specific instructions deviate from those in the Application Guide, follow the program-specific instructions. Applications that do not comply with these instructions may be delayed or not accepted for review.



A compatible version of Adobe Reader is required for download. For Assistance downloading this or any Grants.gov application package, please contact Grants.gov Customer Support at http://www.grants.gov/web/grants/support.html.
Table of Contents

Part 1. Overview Information
Part 2. Full Text of the Announcement

Section I. Funding Opportunity Description
Section II. Award Information
Section III. Eligibility Information
Section IV. Application and Submission Information
Section V. Application Review Information
Section VI. Award Administration Information
Section VII. Agency Contacts
Section VIII. Other Information


Part 2. Full Text of Announcement
Section I. Funding Opportunity Description

 1. Conference Objectives

The Agency for Healthcare Research and Quality (AHRQ), announces its continued interest in supporting conferences through its Conference Grant Program.  A conference is a symposium, seminar, workshop, or any other organized and formal meeting, whether conducted face-to-face or via the Internet, where individuals assemble (or meet virtually, e.g., through webinars) to exchange information and views or explore or clarify a defined subject, problem, or area of knowledge, whether or not a published report results from such meeting. A meeting that is conducted as part of the normal course of doing business is not considered a conference.  AHRQ support for a conference grant will not exceed $50,000 direct costs annually over any project period duration.  Facilities and Administrative (F&A) costs (indirect costs) are not allowed for conference grants.

This Program is intended to complement and promote AHRQ's core research, dissemination, and implementation activities by providing a mechanism for Agency stakeholders and others to:

  • Develop health services research agendas and identify strategies and mechanisms for studying them;
  • Discuss and develop consensus around health services research methodological and technical issues;
  • Disseminate and implement health services research information and tools for formulating or evaluating health policy, and for managing health care programs;
  • Improve quality and effectiveness of health care or purchasing health services; and
  • Develop partnerships with stakeholder organizations and build their capacity to participate in research activities and use the results of health services research.

AHRQ seeks to support conferences that help to further its mission to produce evidence to make health care safer, higher quality, more accessible, equitable and affordable, and to work with HHS and other partners to make sure that the evidence is understood and used. The types of conferences eligible for support include:

  • Research Development - conferences where issues or problems in the practice and delivery of health care are defined and a research agenda or strategy for studying them is developed;
  • Research Design and Methodology - conferences where methodological and technical issues of major importance in the field of health services research are addressed or new study designs and methodologies are developed;
  • Dissemination and Implementation – conferences where research findings and evidence-based information and tools are summarized, communicated and used by organizations and individuals that have the capability to use the information to improve the outcomes, quality, access to, and cost and utilization of health care services. AHRQ is especially interested in supporting conferences that disseminate AHRQ-sponsored evidence and tools and;
  • Research Training, Infrastructure and Career Development - conferences where faculty, trainees and students are brought together with stakeholders to develop, share or disseminate research products, experiences, curricula, syllabi, or competencies. These types of conferences are not for the training of individuals in health services research.

The applicant must clearly identify which type of conference is being proposed.

Conference sessions must include health services research. AHRQ has particular interest in supporting conference grants that support agency priorities.  To learn more about AHRQ’s priorities, please visit (http://www.ahrq.gov/funding/policies/foaguidance/index.html).

The conference should address issues related to priority populations--low income groups; racial and ethnic minority groups; women; children; the elderly; individuals with special health care needs, including individuals with disabilities and those who need chronic care and end-of-life health care; and individuals living in inner-city, rural, and frontier areas--to the extent appropriate to the conference topic.

The topic selected must be important to Agency stakeholders such as consumers and patients; clinicians and other providers; institutions; health plans; purchasers; and policymakers in all sectors (e.g., Federal, State and local governments; voluntary associations; international organizations; and foundations).

AHRQ is especially interested in supporting conferences which include plans for disseminating conference materials and products beyond the participants attending the event.  Such strategies might include, but are not limited to, submitting articles for publication, posting information on a web site and other current forms of social media methods, implementation of conference findings and seeking formal opportunities to discuss conference information with others. 

See Section VIII, Other Information - Required Federal Citations, for policies related to this announcement. 

See Section VIII. Other Information for award authorities and regulations.

Section II. Award Information
Funding Instrument

Mechanism of Support. This Funding Opportunity Announcement (FOA) will use the conference grant (R13) award mechanism.

AHRQ encourages applicants to seek additional sources of support for the proposed conference conferences.  The applicant is solely responsible for planning, directing, and executing the proposed conference.

In addition, examples of AHRQ funded conference grants are available at: https:www.ahrq.gov/funding/fund-opps/sample-applications.html).

Application Types Allowed

New or Resubmission

The OER Glossary and the SF424 (R&R) Application Guide provide details on these application types.

Funds Available and Anticipated Number of Awards

Because the nature and scope of the proposed conferences will vary from application to application, it is anticipated that the size and duration of each award will also vary.  Although the financial plans of AHRQ provide support for this program, the number of awards is contingent upon AHRQ appropriations and the submission of a sufficient number of meritorious applications. Future year amounts will depend on annual appropriations.   

Award Budget

 Direct costs for a project awarded under this FOA will not exceed $50,000 annually. Facilities and administrative (F&A) costs (indirect costs) are not allowed on grants in support of conferences. 

Award Project Period

 The project period may not exceed one year for single-year conference grants and three years for multiple-year conference grants.

  • Although it is anticipated that most applications will request a project period that does not exceed one year, AHRQ will accept applications with a project period of up to three years that support the same conference on an annual basis, if proposed by a permanently sponsoring organization.

Applicants may request full or partial support for conferences. In the case of partially-supported conferences, AHRQ’s objective review will consider the overall structure and design of the conference as well as the sub-component for which support is being requested.

Note: After 3 consecutive years of funding for the same conference topic applicants are no longer eligible to apply for the single-year funding but must apply for multiple-year conference support.

While grant awards are made to institutions rather than individuals, this announcement and its instructions are written to inform individual researchers of this funding opportunity and facilitate the submission of grant applications by their organizations.    

These projects are authorized by 42 U.S.C. 299a, which provides that AHRQ shall conduct and support research, support demonstration projects, and disseminate information on health care and on systems for the delivery of such care, including activities with respect to the quality, effectiveness, efficiency, appropriateness, and value of health care services.

All applications submitted and AHRQ grants made in response to this FOA are subject to 45 CFR Part 75 (Uniform Administrative Requirements, Cost Principles and Audit Requirements for HHS Awards; http://www.ecfr.gov/cgi-bin/text-idx?node=pt45.1.75) , the HHS Grants Policy Statement (see http://www.ahrq.gov/funding/policies/hhspolicy/index.html and  http://www.hhs.gov/asfr/ogapa/aboutog/hhsgps107.pdf), and the terms and conditions set forth in the Notice of Award.

Section III. Eligibility Information
1. Eligible Applicants
Eligible Organizations

You may submit an application(s) if your institution/organization is a (an):

  • Public or non-profit private institution, such as a university, college, or a faith-based or community-based organization;
  • Unit of local or State government;
  • Eligible agency of the Federal government.
  • Indian/Native American Tribal Government (Federally recognized)
  • Indian/Native American Tribal Government (Other than Federally recognized);
  • Indian/Native American Tribally Designated Organization.

The following types of Higher Education Institutions are always encouraged to apply for AHRQ support as Public or Non-Profit Private Institutions of Higher Education:

  • Hispanic-serving Institutions
  • Historically Black Colleges and Universities (HBCUs)
  • Tribally Controlled Colleges and Universities (TCCUs)
  • Alaska Native and Native Hawaiian Serving Institutions
  • Asian American Native American Pacific Islander Serving Institutions (AANAPISIs)

AHRQ’s authorizing legislation does not allow for-profit organizations to be eligible to lead applications under this research mechanism.  For-profit organizations may participate in projects as members of consortia or as subcontractors only.  Because the purpose of this program is to improve healthcare in the United States, foreign institutions may participate in projects as members of consortia or as subcontractors only.  Applications submitted by for-profit organizations or foreign institutions will not be reviewed.  Organizations described in section 501(c) 4 of the Internal Revenue Code that engage in lobbying are not eligible.

HHS grants policy requires that the grant recipient perform a substantive role in the conduct of the planned project or program activity and not merely serve as a conduit of funds to another party or parties. If consortium/contractual activities represent a significant portion of the overall project, the applicant must justify why the applicant organization, rather than the party(s) performing this portion of the overall project, should be the grantee and what substantive role the applicant organization will play. Justification can be provided in the Specific Aims or Research Strategy section of the PHS398 Research Plan Component sections of the SF424 (R&R) application.  There is no budget allocation guideline for determining substantial involvement; determination of substantial involvement is based on a review of the primary project activities for which grant support is provided and the organization(s) that will be performing those activities.

Foreign Institutions

Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

Required Registrations

Applicant Organizations

Applicant organizations must complete and maintain the following registrations as described in the SF 424 (R&R) Application Guide to be eligible to apply for or receive an award. All registrations must be completed prior to the application being submitted. Registration can take 6 weeks or more, so applicants should begin the registration process as soon as possible. The NIH Policy on Late Submission of Grant Applications states that failure to complete registrations in advance of a due date is not a valid reason for a late submission.

  • Dun and Bradstreet Universal Numbering System (DUNS) - All registrations require that applicants be issued a DUNS number. After obtaining a DUNS number, applicants can begin both SAM and eRA Commons registrations. The same DUNS number must be used for all registrations, as well as on the grant application.
  • System for Award Management (SAM) (formerly CCR) – Applicants must complete and maintain an active registration, which requires renewal at least annually. The renewal process may require as much time as the initial registration. SAM registration includes the assignment of a Commercial and Government Entity (CAGE) Code for domestic organizations which have not already been assigned a CAGE Code.
  • NATO Commercial and Government Entity (NCAGE) Code – Foreign organizations must obtain an NCAGE code (in lieu of a CAGE code) in order to register in SAM. 
  • eRA Commons - Applicants must have an active DUNS number and SAM registration in order to complete the eRA Commons registration. Organizations can register with the eRA Commons as they are working through their SAM or Grants.gov registration. eRA Commons requires organizations to identify at least one Signing Official (SO) and at least one Program Director/Principal Investigator (PD/PI) account in order to submit an application.
  • Grants.gov – Applicants must have an active DUNS number and SAM registration in order to complete the Grants.gov registration.

Program Directors/Principal Investigators (PD(s)/PI(s))

The PD/PI must have an eRA Commons account.  The PD/PI should work with his/her organizational officials to either create a new account or to affiliate their existing account with the applicant organization in eRA Commons. If the PD/PI is also the organizational Signing Official, he/she must have two distinct eRA Commons accounts, one for each role. Obtaining an eRA Commons account can take up to 2 weeks.

Eligible Individuals (Program Director/Principal Investigator)

Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director/Principal Investigator (PD/PI) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for AHRQ support.

Only one PD/PI may be designated on the application.

2. Cost Sharing

This FOA does not require cost sharing.

While there is no cost sharing requirement included in this FOA, AHRQ welcomes applicant institutions, including any collaborating institutions, to devote resources to this effort.  An indication of institutional support from the applicant and its collaborators indicates a greater potential of success and sustainability of the project.  Examples of institutional support would include: donated equipment and space, institutional funded staff time and effort, or other resource investments.  Applicant institutions should indicate institutional support by outlining the specific contributions to the project and providing assurances that their organization and any collaborators are committed to providing these funds and resources to the project. This information can be included at the end of the budget justification section of the application, but institutional support dollars are not to be shown/included in the detailed budget request. 

3. Additional Information on Eligibility
Number of Applications

Applicant organizations may submit more than one application, provided that each application is scientifically distinct.

AHRQ will not accept duplicate or highly overlapping applications under review at the same time.  This means that AHRQ will not accept:

  • A new (A0) application that is submitted before issuance of the summary statement from the review of an overlapping new (A0) or resubmission (A1) application.
  • A resubmission (A1) application that is submitted before issuance of the summary statement from the review of the previous new (A0) application.
  • An application that has substantial overlap with another application pending appeal of initial peer review (see NOT-OD-11-101).
Section IV. Application and Submission Information
1. Requesting an Application Package

Buttons to access the online ASSIST system or to download application forms are available in Part 1 of this FOA. See your administrative office for instructions if you plan to use an institutional system-to-system solution.

2. Content and Form of Application Submission

It is critical that applicants follow the instructions in the Research Instructions for the SF424 (R&R) Application Guide, including Supplemental Grant Application Instructions except where instructed in this funding opportunity announcement to do otherwise. Conformance to the requirements in the Application Guide is required and strictly enforced. Applications that are out of compliance with these instructions may be delayed or not accepted for review.

For information on Application Submission and Receipt, visit Frequently Asked Questions – Application Guide, Electronic Submission of Grant Applications.

Letter of Intent

A letter of intent is not required for this funding opportunity.

Page Limitations

All page limitations described in the SF424 Application Guide and the Table of Page Limits must be followed.

Instructions for Application Submission

The following section supplements the instructions found in the SF424 (R&R) Application Guide and should be used for preparing an application to this FOA.

SF424(R&R) Cover

All instructions in the SF424 (R&R) Application Guide must be followed.  

SF424(R&R) Project/Performance Site Locations

All instructions in the SF424 (R&R) Application Guide must be followed.  

SF424(R&R) Other Project Information

All instructions in the SF424 (R&R) Application Guide must be followed.  

SF424(R&R) Senior/Key Person Profile

All instructions in the SF424 (R&R) Application Guide must be followed. 

R&R or Modular Budget

All instructions in the SF424 (R&R) Application Guide must be followed, with the following additional instructions:

Budget Component:  Special Instructions for AHRQ applications

AHRQ is not using the Modular Grant Application and Award Process.  Applicants for funding from AHRQ are to ignore application instructions concerning the Modular Grant Application and Award Process, and prepare applications using instructions for the Research and Related Budget Components of the SF 424 (R&R).  Applications submitted in the Modular format will not be reviewed.

R&R Subaward Budget

All instructions in the SF424 (R&R) Application Guide must be followed.

PHS 398 Cover Page Supplement

All instructions in the SF424 (R&R) Application Guide must be followed.  

PHS 398 Research Plan

All instructions in the SF424 (R&R) Application Guide that are not otherwise specified within this Funding Opportunity Announcement must be followed, with the following additional instructions:

Appendix:  Do not use the Appendix to circumvent page limits. Follow all instructions for the Appendix as described in the SF424 (R&R) Application Guide.

PHS Inclusion Enrollment Report

Form only available in FORMS-D application packages for use with due dates on or before January 24, 2018.

When conducting clinical research, follow all instructions for completing PHS Inclusion Enrollment Report as described in the SF424 (R&R) Application Guide.

PHS Human Subjects and Clinical Trials Information

Form only available in FORMS-E application packages for use with due dates on or after January 25, 2018.

When involving NIH-defined human subjects research, clinical research, and/or clinical trials follow all instructions for the PHS Human Subjects and Clinical Trials Information form in the SF424 (R&R) Application Guide, with the following additional instructions:

If you answered "Yes" to the question "Are Human Subjects Involved?" on the R&R Other Project Information form, you must include at least one human subjects study record using the Study Record: PHS Human Subjects and Clinical Trials Information form or a Delayed Onset Study record.

Study Record: PHS Human Subjects and Clinical Trials Information
All instructions in the SF424 (R&R) Application Guide must be followed.

Delayed Onset Study: All instructions in the SF424 (R&R) Application Guide must be followed.

PHS Assignment Request Form

All instructions in the SF424 (R&R) Application Guide must be followed. 

3. Unique Entity Identifier and System for Award Management (SAM)

See Part 1. Section III.1 for information regarding the requirement for obtaining a unique entity identifier and for completing and maintaining active registrations in System for Award Management (SAM), NATO Commercial and Government Entity (NCAGE) Code (if applicable), eRA Commons, and Grants.gov

4. Submission Dates and Times

Part I. Overview Information contains information about Key Dates and times. Applicants are encouraged to submit applications before the due date to ensure they have time to make any application corrections that might be necessary for successful submission. When a submission date falls on a weekend or Federal holiday, the application deadline is automatically extended to the next business day.

Organizations must submit applications to Grants.gov (the online portal to find and apply for grants across all Federal agencies). Applicants must then complete the submission process by tracking the status of the application in the eRA Commons, NIH’s electronic system for grants administration. NIH and Grants.gov systems check the application against many of the application instructions upon submission. Errors must be corrected and a changed/corrected application must be submitted to Grants.gov on or before the application due date and time.  If a Changed/Corrected application is submitted after the deadline, the application will be considered late. Applications that miss the due date and time are subjected to the NIH Policy on Late Application Submission.

Applicants are responsible for viewing their application before the due date in the eRA Commons to ensure accurate and successful submission.

Information on the submission process and a definition of on-time submission are provided in the SF424 (R&R) Application Guide.

5. Intergovernmental Review (E.O. 12372)

This initiative is not subject to intergovernmental review.

6. Funding Restrictions

For efficient grant administration, AHRQ grant administration procedures will be used and conducted in accordance with the terms and conditions, cost principles, and other considerations described in the HHS Grants Policy Statement. The Grants Policy Statement can be found at http://www.ahrq.gov/funding/grants/policies/hhspolicy.html.

An award will not be made if the conference date for which support is requested has passed.  The conference must be held within 12 months of the budget period start date of the award.

Pre-award costs are allowable. A grantee may, at its own risk and without AHRQ prior approval, incur obligations and expenditures to cover costs up to 90 days before the beginning date of the initial budget period of a new award if such costs are necessary to conduct the project and would be allowable under the grant, if awarded, without AHRQ prior approval. If specific expenditures would otherwise require prior approval, the grantee must obtain AHRQ approval before incurring the cost. AHRQ prior approval is required for any costs to be incurred more than 90 days before the beginning date of the initial budget period of a new award.

The incurrence of pre-award costs in anticipation of a competing or non-competing award imposes no obligation on AHRQ either to make the award or to increase the amount of the approved budget if an award is made for less than the amount anticipated and is inadequate to cover the pre-award costs incurred. AHRQ expects the grantee to be fully aware that pre-award costs result in borrowing against future support and that such borrowing must not impair the grantee's ability to accomplish the project objectives in the approved time frame or in any way adversely affect the conduct of the project.

7. Other Submission Requirements and Information

Applications must be submitted electronically following the instructions described in the SF424 (R&R) Application Guide.  Paper applications will not be accepted.

Applicants must complete all required registrations before the application due date. Section III. Eligibility Information contains information about registration.

For assistance with your electronic application or for more information on the electronic submission process, visit Applying Electronically. If you encounter a system issue beyond your control that threatens your ability to complete the submission process on-time, you must follow the Guidelines for Applicants Experiencing System Issues. For assistance with application submission, contact the Application Submission Contacts in Section VII.

Important reminders:

The PD/PI must include his/her eRA Commons ID in the Credential field of the Senior/Key Person Profile Component of the SF424(R&R) Application Package. Failure to register in the Commons and to include a valid PD/PI Commons ID in the credential field will prevent the successful submission of an electronic application to AHRQ. See Section III of this FOA for information on registration requirements.

The applicant organization must ensure that the DUNS number it provides on the application is the same number used in the organization’s profile in the eRA Commons and for the System for Award Management. Additional information may be found in the SF424 (R&R) Application Guide.

See more tips for avoiding common errors.

SPECIAL BUDGET REQUIREMENTS:

Applications may request full or partial support for conferences.

AHRQ will support up to $50,000 direct costs annually.  Facilities and Administration Costs (F&A) (indirect costs) are not allowed on grants in support of conferences.

Where partial support of a conference is requested from AHRQ, peer reviewers will consider the overall structure and design of the conference as well as the sub-component, if applicable, for which support is being requested.

Sources and amounts of other funding for the conference must be clearly identified.  In addition to including the required detailed budget reflecting the amount of funding requested from AHRQ, applications must include a composite categorical budget, including additional sources of funding, (in the Budget Justification section of the Research & Related Budget Component of the SF424) for the total cost of the conference including all anticipated sources of funding.  Applications that do not include a composite budget will not undergo peer review or funding consideration.  Any anticipated program income (e.g., registration fees) should be specified as one source of funding.  Note: Program income may not be used for otherwise unallowable costs.

Allowable and Unallowable Costs

Expenses allowed under the Conference Grant Program follow the guidelines described in the HHS Grants Policy Statement (http://www.ahrq.gov/fund/hhspolicy.htm), unless otherwise stated in this funding opportunity announcement.  Areas of particular relevance to conference grants and exceptions to the general policies are described below.

Direct Cost Expenditures

a. Equipment.  Grant funds may be used for rental of necessary equipment for the conference. Funds may not be used for the purchase of equipment. Rental expenses should be listed under the other expenses category.

b. Travel.  Proposed per diem or subsistence allowances must be reasonable and will be limited to the days of attendance at the conference plus actual travel time required to reach the conference location by the most direct route available. Travel costs are limited to the extent provided for by formal institutional travel policy. If the grantee institution has no formal travel policy, the Department of Health and Human Services travel regulations shall be applied in determining the amount of travel chargeable to grant funds. Where meals and/or lodging are furnished without charge or at a nominal cost, the proposed per diem or subsistence allowance must take this into consideration. Transportation costs for those attending and participating in the conference and paid with grant funds may not exceed economy class fares. U.S. carriers must be used where possible. For local participants in the conference, grant funds may not be used to pay per diem or expenses other than local mileage.

c. Supplies.  Grant funds may be used for the purchase of conference supplies, provided the supplies are received and used during the project period.

d. Conference Services. Grant funds may be used for necessary recording of proceedings, simultaneous translation, and subsequent transcriptions.

e. Publication Costs.  Grant funds may be used to pay for the publication and dissemination of conference proceedings.

f. Registration Fees.  Charges for registration fees may NOT be paid from grant funds.

g. Entertainment and Personal Expenses.  Costs of amusement, diversion, social activities, ceremonials, and related incidental costs such as meals, lodging, rentals, transportation, gratuities, bar charges and personal telephone calls of participants or guests, are not allowable.

h. Federal Employees.  Grant funds may not be used to cover the cost of travel or any payment to a full-time Federal employee, except when that employee is on leave without pay status from his or her employing office.

i. Honoraria. Honoraria or other payments given for the purpose of conferring distinction on or to symbolize respect, esteem, or admiration for the recipient may not be paid from grant funds. Speaker fees for services rendered, however, are allowable.

j. Alteration and Renovations.  Grant funds may not be used to support facility alteration or renovations of any kind.

k. Food.  Grant funds may NOT be used for the purchase of food of any kind (refreshments, meals, etc.).  AHRQ will not award funds to support the cost of food for any conference grant.

l. Promotional Items.  Grant funds may NOT be used for the purchase of promotional items which include, but are not limited to, clothing and commemorative items such as pens, mugs/cups, folders/folios, lanyards, and conference bags.

m. Salaries.  In accordance with the established policies of the recipient, salaries of professional personnel, clerical assistants, editorial assistants, and other nonprofessional staff are allowable, but only in proportion to the time or effort spent directly related to the conference/meeting.

n. Consultant Services.  Consultant fees, including travel and supporting costs (e.g. per diem) are allowable.

The following costs are NOT allowable costs:

  • Purchase of equipment
  • Transportation costs exceeding U.S. carrier coach class fares; cost of visas or passports
  • Entertainment; tips; bar charges
  • Personal telephone calls; laundry charges; dues
  • Honoraria or other payments for the purpose of conferring distinction or communicating respect, esteem, or admiration for the recipient
  • Patient care
  • Alterations or renovations
  • Facilities and administrative (F&A) costs/indirect costs
  • Registration fees
  • CME credits or cost associated with obtaining CME certification
  • Purchase of food (refreshments, meals, or otherwise)
  • Purchase of promotional items

Note:   The list above is not all inclusive.  The applicant should contact AHRQ staff regarding any other items being considered for which there are questions regarding whether or not the items are allowed to be included.  Please also refer to the HHS Grants Policy Statement for additional information regarding costs.

Warning:  Please be sure that you observe the total cost, project period, and page number limitations specified above for this FOA. Application processing may be delayed or the application may be rejected if it does not comply with these requirements

Upon receipt, applications will be evaluated for completeness and compliance with application instructions by the Center for Scientific Review, NIH and for responsiveness by AHRQ.  Applications that are incomplete or non-compliant will not be reviewed.

In order to expedite the review, applicants are requested to notify the AHRQ Referral Office by email Gerald.Calderone@ahrq.hhs.gov when the application has been submitted.  Please include the FOA number and title, PD/PI name, and title of the application.

Although there is no immediate acknowledgement of the receipt of an application, applicants are generally notified of the review and funding assignment within eight (8) weeks.

Priority Populations

AHRQ supports research, evaluations, and demonstration projects concerning the delivery of health care in inner-city and rural areas (including frontier areas), and health care for priority populations.  Priority populations include low income groups; minority groups; women; children; the elderly; and individuals with special health care needs, including individuals with disabilities and individuals who need chronic care or end-of-life health care.  42 USC 299(c).  Women and members of minority groups are included in all AHRQ-supported research projects involving human subjects, unless a clear and compelling rationale and justification is provided that inclusion is inappropriate, e.g. because of the lack of connection between the study and the health of women or particular minorities.  Investigators should review the document entitled, “AHRQ Policy on the Inclusion of Priority Populations,” which is available http://grants.nih.gov/grants/guide/notice-files/NOT-HS-03-010.html.  Applicants under this FOA should consider and discuss including priority populations in the research design as specified in this Notice.

Plan for Sharing Research Data

The precise content of the data-sharing plan will vary, depending on the data being collected and how the investigator is planning to share the data. Applicants who are planning to share data may wish to describe briefly the expected schedule for data sharing; the format of the final dataset; the documentation to be provided; whether or not any analytic tools also will be provided; whether or not a data-sharing agreement will be required and, if so, a brief description of such an agreement (including the criteria for deciding who can receive the data and whether or not any conditions will be placed on their use); and the mode of data sharing (e.g., under its own auspices by mailing a disk or posting data on its institutional or personal website or through a data archive or enclave). Investigators choosing to share under their own auspices may wish to enter into a data-sharing agreement. References to data sharing may also be appropriate in other sections of the application.

The reasonableness of the data sharing plan or the rationale for not sharing research data will be assessed by the reviewers. However, reviewers will not factor the proposed data sharing plan into the determination of scientific merit or the priority score.

Public Access to AHRQ-Funded Scientific Publications

Investigators should review the document titled ‘AHRQ Announces new Policy for Public Access to AHRQ-Funded Scientific Publications’ which is available at (http://grants.nih.gov/grants/guide/notice-files/NOT-HS-16-008.html).  For all research arising from AHRQ support, this policy requires that AHRQ-funded authors submit an electronic version of the author’s final peer-reviewed accepted manuscript to the National Library of Medicine's PubMed Central (PMC) to be made publicly available within 12 months of the publisher’s date of publication.

Data Confidentiality

The AHRQ confidentiality statute, 42 USC 299c-3(c), requires that information that is obtained in the course of AHRQ supported activities and that identifies individuals or establishments be used only for the purpose for which it was supplied.  Information that is obtained in the course of AHRQ-supported activities and that identifies an individual may be published or released only with the consent of the individual who supplied the information or is described in it.  There are civil monetary penalties for violation of the confidentiality provision of the AHRQ statute. 42 USC 299c-3(d).  In the Human Subjects section of the application, applicants must describe procedures for ensuring the confidentiality of the identifying information to be collected.  The description of the procedures should include a discussion of who will be permitted access to this information, both raw data and machine readable files, and how personal identifiers and other identifying or identifiable data will be restricted and safeguarded.  Identifiable patient health information collected by grantees under this FOA will also be obtained and managed in accordance with the HIPAA Privacy Rule, 45 CFR Parts 160 and 164. 

The grantee should ensure that computer systems containing confidential data have a level and scope of security that equals or exceeds that established by the HIPAA Security Rules, if applicable, and that established by the Office of Management and Budget (OMB) in OMB Circular No. A-130, Appendix III - Security of Federal Automated Information Systems. The applicability and intended means of applying these confidentiality and security standards to subcontractors and vendors, if any, should be addressed in the application.

Sharing Research Resources:  Rights in Data

Unless otherwise provided in grant awards, AHRQ grantees may copyright, or seek patents for, as appropriate, final and interim products and materials developed in whole or in part with AHRQ support, including, but not limited to, methodological tools, measures, software with documentation, literature searches, and analyses.  Such copyrights and patents are subject to a royalty-free, non-exclusive, and irrevocable AHRQ license to reproduce, publish, use or disseminate for any purpose consistent with AHRQ’s statutory responsibilities and to authorize others to do so for any purpose consistent with AHRQ’s statutory responsibilities. In accordance with its legislative dissemination mandate, AHRQ purposes may include, subject to statutory confidentiality protections, making project materials, databases, results, and algorithms available for verification or replication by other researchers.  In addition, subject to AHRQ budget constraints, final products may be made available to the health care community and the public by AHRQ or its agents if such distribution would significantly increase access to a product and thereby produce substantial or valuable public health benefits.  Ordinarily, to accomplish distribution, AHRQ publicizes research findings but relies on grantees to publish research results in peer-reviewed journals and to market grant-supported products. 

AHRQ requests that grantees notify the Office of Communications (OC) when an AHRQ-funded research article has been accepted for publication in a peer-reviewed journal. Researchers should submit manuscripts that have been accepted for publication in a peer-reviewed journal to JournalPublishing@ahrq.hhs.gov at least four to six weeks in advance of the journal’s expected publication date. 

Regulations applicable to AHRQ grantees concerning intangible rights and copyright can be found at 45 CFR 75.322.

Post Submission Materials

Applicants are required to follow our Post Submission Application Materials policy.

Section V. Application Review Information
1. Criteria

The mission of AHRQ is to produce evidence to make health care safer, higher quality, more accessible, equitable, and affordable, and to work with the U.S. Department of Health and Human Services (HHS) and other partners to make sure that the evidence is understood and used.  

AHRQ's priority areas of focus are:

  • Improve health care quality by accelerating implementation of patient-centered outcomes research (PCOR).
  • Make health care safer.
  • Increase accessibility by evaluating Affordable Care Act (ACA) coverage expansions.
  • Improve health care affordability, efficiency, and cost transparency.

As part of this mission, applications submitted to AHRQ to support health services research are evaluated for scientific and technical merit through the AHRQ peer review system. 

Applications that are complete and responsive to the FOA will be evaluated for scientific and technical merit by an appropriate peer review group convened in accordance with standard AHRQ peer review procedures that are described in 42 CFR Part 67, Subpart A.  Incomplete and/or non-responsive applications or applications not following instructions given in this FOA will not be reviewed.  Only the review criteria described below will be considered in the review process.

Administrative Criteria:  Upon receipt, applications will be evaluated for completeness by the Center for Scientific Review, NIH, and for responsiveness by AHRQ.

Merit Review Criteria:  Merit Review Criteria, as described below, will be considered in the review process.

Overall Impact

Reviewers will provide an overall impact score to reflect their assessment of the likelihood for the project to exert a sustained, powerful influence on the research field(s) involved, in consideration of the following review criteria and additional review criteria (as applicable for the project proposed).

Scored Review Criteria

Reviewers will consider each of the review criteria below in the determination of scientific merit, and give a separate score for each. An application does not need to be strong in all categories to be judged likely to have major scientific impact. For example, a project that by its nature is not innovative may be essential to advance a field.

Significance
  • Does the conference address an important problem or a critical barrier to progress in the field? Is there a strong scientific premise for the project? If the aims of the project are achieved, how will scientific knowledge, technical capability, and/or clinical practice be improved? How will successful completion of the aims change the concepts, methods, technologies, treatments, services, or preventative interventions that drive this field?
  • The topic selected must clearly address AHRQ's mission to produce evidence to make health care safer, higher quality, more accessible, equitable and affordable, and to work with HHS and other partners to make sure that the evidence is understood and used.
  • The conference topic and objective(s) must be succinctly and clearly stated, and reflected in all aspects of the conference proposal
  • Conference sessions must include health services research. AHRQ has particular interest in supporting conference grants that support AHRQ priorities.  To learn more about AHRQ’s priorities (See: http://www.ahrq.gov/funding/policies/foaguidance/index.html ).
  • The conference should address issues related to priority populations--low income groups; racial and ethnic minority groups; women; children; the elderly; individuals with special health care needs, including individuals with disabilities and those who need chronic care and end-of-life health care; and individuals living in inner-city, rural, and frontier areas--to the extent appropriate to the conference topic.
  • The topic selected must be important to Agency stakeholders such as consumers and patients; clinicians and other providers; health care institutions; health plans; purchasers; and policymakers in all sectors (e.g., Federal, State and local governments; voluntary associations; international organizations; and foundations).
  • The products of the conference should have the potential to inform future research, policy, practice, training of health services researchers, or enhance AHRQ's collaborative relationships.
  • Expected conference outcomes should have a national or regional impact or make a significant contribution to a particular field. If the conference is state or regionally based, plans for a broad dissemination of conference materials and some indication of national relevance must be included.
Investigator(s)

Are the PD/PI, collaborators, and other researchers well suited to carry out this work? Is the work proposed appropriate to the experience level of the PD/PI and other researchers? Do the PD/PI and investigative team bring complementary and integrated expertise to the project (if applicable)? Does the conference planning staff and/or advisors include persons with the requisite education, training and experience

Innovation

Is the conference design original and innovative? For example: Does the project challenge current research or seek to shift clinical practice paradigms; address an innovative hypothesis or critical barrier to progress in the field? Does the conference develop or employ novel concepts, approaches or methodologies, tools, or technologies for this area?  

Approach

Are the overall strategy, methodology, and analyses well-reasoned and appropriate to accomplish the specific aims of the project? Have the investigators presented strategies to ensure a robust and unbiased approach, as appropriate for the work proposed? Are potential problems, alternative strategies, and benchmarks for success presented? If the project is in the early stages of development, will the strategy establish feasibility and will particularly risky aspects be managed?

A. Does the applicant clearly identify the conference type/category?  The conference must be for the purpose of one of the following categories: 1. disseminate research results; 2. formulate a research agenda; 3. develop a research methodology; or 4. research training, infrastructure and career development.

B. If the meeting format includes a call for abstracts, the application should include a summary of the process for soliciting, reviewing and selecting research to be presented at the conference.

C. The conference format must support the conference purpose and facilitate expected outcomes.  Conferences convened virtually are expected to cost less).

D. If a planning committee is included, it should include representation from the research, implementation and user communities, and include a process for outreach to a subset of the conference target audience. To the extent consistent with the conference design, topic and goal(s), the planning process should include outreach to people of differing views, and outreach to representatives of one or more of the Agency priority populations.

E. Speakers selected or proposed, or criteria for speaker selection, must be appropriate for the session topic. A plan should be in place to identify other presenters if those originally sought are unavailable.

F. Evaluation of the conference results must be included in the design.

G. A draft agenda with supporting details and speakers should be included.

H. Conference date and venue are stated in project description or conference plan section.

Regionally based conferences are expected to have a plan to disseminate products and/or outcomes nationally  

Environment

Does the environment in which the conference is being planned contribute to the probability of success? Does the proposed conference benefit from unique features of the environment or employ useful collaborative arrangements? Is there evidence of institutional support? Does the applicant organization have the institutional resources, infrastructure, and demonstrated capacity to support the proposed conference?  

Additional Review Criteria

As applicable for the proposed conference, reviewers will consider the following additional items while determining scientific and technical merit, and in providing an overall impact score, but will not give separate scores for these items.

 Budget:  Is the proposed budget reasonable and is the requested period of support appropriate in relation to the proposed conference? Is a composite budged included? Justification must be provided for conferences held by webinar or other virtual technology.

Degree of responsiveness:  How well does the application address the purpose and objectives of this FOA?  Is the application responsive to the special eligibility criteria noted in the FOA?

Resubmission Applications (formerly "revised/amended" applications):  Are the responses to comments from the previous scientific review group adequate? Are the improvements in the resubmission application appropriate?

Protections for Human Subjects

For research that involves human subjects but does not involve one of the six categories of research that are exempt under 45 CFR Part 46, the committee will evaluate the justification for involvement of human subjects and the proposed protections from research risk relating to their participation according to the following five review criteria: 1) risk to subjects, 2) adequacy of protection against risks, 3) potential benefits to the subjects and others, 4) importance of the knowledge to be gained, and 5) data and safety monitoring for clinical trials.

For research that involves human subjects and meets the criteria for one or more of the six categories of research that are exempt under 45 CFR Part 46, the committee will evaluate: 1) the justification for the exemption, 2) human subjects involvement and characteristics, and 3) sources of materials. For additional information on review of the Human Subjects section, please refer to the Guidelines for the Review of Human Subjects.

Degree of Responsiveness 

Reviewers will assess how well the application addresses the purpose and objectives of this FOA.  How responsive is the application to the special eligibility criteria, including the project requirements, noted in the FOA? [NOTE: Information may be added here]

Inclusion of Priority Populations

Reviewers will assess the adequacy of plans to address the needs of both genders, racial and ethnic minorities (and subgroups).  Reviewers will assess the adequacy of attention to AHRQ priority populations (see above discussion on Priority Populations in section IV.6 “Other Submission Requirements”).

Budget and Period of Support

The committee will evaluate whether the proposed budget is reasonable and whether the requested period of support is appropriate in relation to the proposed research. [NOTE: Information may be added here.

Privacy and Security Protections for Patients

Reviewers will assess the resources and processes to be used to address privacy and security issues in the development and implementation of the intervention [NOTE: use this as appropriate. ]

Resubmissions

For Resubmissions, the committee will evaluate the application as now presented, taking into consideration the responses to comments from the previous scientific review group and changes made to the project.

Renewals

For Renewals, the committee will consider the progress made in the last funding period.

Additional Review Considerations

As applicable for the project proposed, reviewers will consider each of the following items, but will not give scores for these items, and should not consider them in providing an overall impact score.

  Not applicable. 

2. Review and Selection Process

Applications will be evaluated for scientific and technical merit by (an) appropriate Scientific Review Group , in accordance with AHRQ review policy and procedures, using the stated review criteria. Assignment to a Scientific Review Group will be shown in the eRA Commons.

As part of the scientific peer review, all applications:

  • May undergo a selection process in which only those applications deemed to have the highest scientific and technical merit (generally the top half of applications under review) will be discussed and assigned an overall impact score.
  • Will receive a written critique.

Applications will be assigned on the basis of established AHRQ referral guidelines to the appropriate AHRQ Office or Center. Applications will compete for available funds with all other recommended applications submitted in response to this FOA. The following will be considered in making funding decisions:

  • Scientific and technical merit of the proposed project as determined by peer review.
  • Availability of funds.
  • Responsiveness to goals and objectives of the FOA.
  • Relevance and fit within AHRQ research priorities, as well as overall programmatic and geographic balance.
3. Anticipated Announcement and Award Dates

After the peer review of the application is completed, the PD/PI will be able to access his or her Summary Statement (written critique) via the eRA Commons. Refer to Part 1 for dates for peer review, advisory council review, and earliest start date.

Generally, applicants should anticipate eight months between the application submission date and the earliest possible start date.

Section VI. Award Administration Information
1. Award Notices

If the application is under consideration for funding, AHRQ will request "Just-In-Time" information from the applicant.  Just-In-Time information generally consists of information on other support and any additional information necessary to address administrative and budgetary issues.

If all administrative and programmatic issues are resolved, a formal notification in the form of a Notice of Award (NoA) will be provided to the applicant organization for successful applications. The NoA signed by the AHRQ grants management officer is the authorizing document and will be sent via email to the grantee’s business official.

Awardees must comply with any funding restrictions described in Section IV.5. Funding Restrictions.

In addition to the standard grant requirements, the grantee is required to comply with the following terms and conditions:

1. Agreement to hold the conference within 12 months of the budget period start date of the award.

2. The understanding that under no circumstance will support be provided for conferences held prior to the budget period start date of the grant award.

3. Agreement to submit to AHRQ, no later than 90 days after the dates of the conference, an original and two copies of an executive summary and one-page abstract of the conference and summary of participant's evaluation ratings/comments.  This summary should include a discussion of what was learned from the conference, as well as what might be done differently in the future based on lessons learned.  At the time of the award, the program official will determine how many copies of the conference products will be required for distribution to AHRQ staff and other DHHS colleagues.

4. To the extent relevant to the particular conference design, topic and goal, agreement to disseminate germane AHRQ product(s).

5. Agreement to list AHRQ as a conference supporter on conference materials, subsequent proceedings and references. Note that AHRQ is not to be listed as a sponsor of the conference.

6. Applicants who list or name AHRQ staff who have agreed to participate in a conference as speakers or presenters must include a letter of agreement.

Selection of an application for award is not an authorization to begin performance.  Any costs incurred before receipt of the NOA are at the recipient’s risk.  These costs may be reimbursed only to the extent considered allowable pre-award costs.  See also Section IV.5., “Funding Restrictions.”

Any application awarded in response to this FOA will be subject to the DUNS, SAM Registration, and Transparency Act requirements as noted on the AHRQ web site at http://www.ahrq.gov/funding/grant-mgmt/index.html.

2. Administrative and National Policy Requirements

All AHRQ grant and cooperative agreement awards are subject to OMB's Uniform Grant Guidance, HHS’s “Uniform Administrative Requirements, Cost Principles, and Audit Requirements for HHS Awards,” (http://www.ecfr.gov/cgi-bin/text-idx?node=pt45.1.75), and the HHS Grants Policy Statement (see http://www.ahrq.gov/funding/policies/hhspolicy/index.html), and the terms and conditions set forth in the Notice of  Award.

A standard term and condition of award will be included in the Notice of Award (NOA) that states:  “in any grant-related activity in which family, marital, or household consideration are, by statute or regulation, relevant for purposes of determining beneficiary eligibility or participation, grantees must treat same-sex spouses, marriages, and households on the same terms as opposite-sex spouses, marriages, and households, respectively. By “same-sex spouses,” HHS means individuals of the same sex who have entered into marriages that are valid in the jurisdiction where performed, including any of the 50 states, the District of Columbia, or a U.S. territory or in a foreign country, regardless of whether or not the couple resides in a jurisdiction that recognizes same-sex marriage.  By “same-sex marriages,” HHS means marriages between two individuals validly entered into in the jurisdiction where performed, including any of the 50 states, the District of Columbia, or a U.S. territory or in a foreign country, regardless of whether or not the couple resides in a jurisdiction that recognizes same-sex marriage.  By “marriage,” HHS does not mean registered domestic partnerships, civil unions or similar formal relationships recognized under the law of the jurisdiction of celebration as something other than a marriage.”

All applicants will be subject to a term and condition that applies the terms of 48 CFR section 3.908 to the award, and requires that grantees inform their employees in writing of employee whistleblower rights and protections under 41U.S.C. 4712 in the predominant native language of the workforce.

As necessary, additional Terms and Conditions will be incorporated into the NoA.

Cooperative Agreement Terms and Conditions of Award

Not Applicable

3. Reporting

Awardees are required to submit, no later than 90 days after the dates of the conference, an original and two copies of an executive summary and one-page abstract of the conference and summary of participant's evaluation ratings/comments.  This summary should include a discussion of what was learned from the conference, as well as what might be done differently in the future based on lessons learned. 

When multiple years are involved, awardees will be required to submit the Research Performance Progress Report (RPPR) annually unless specified otherwise in the terms of the award.   Grantees are required to submit expenditure data on the Federal Financial Report (FFR; SF 425) annually.

For details regarding progress report submission, refer to http://www.ahrq.gov/fund/noncomp.htm.  If instructions on the AHRQ website are different from the RPPR Instructions, follow the instructions on the AHRQ website. Progress reports are due 3 months before the anniversary of the award. In addition to the annual progress report, recipients may be required to submit quarterly progress reports to AHRQ. If applicable, detailed instructions on additional reporting requirements will be provided with the grant award.

Expenditure data is to be reported on the Federal Financial Report (FFR; SF 425). AHRQ requires annual financial expenditure reports for ALL grant programs as described in the HHS Grants Policy Statement (http://www.ahrq.gov/fund/hhspolicy.htm).  AHRQ implementation of the FFR retains a financial reporting period that coincides with the budget period of a particular project.  However, the due date for annual FFRs is 90 days after the end of the calendar quarter in which the budget period ends.  For example, if the budget period ends 4/30/2015, the annual FFR is due 9/30/2015 (90 days after the end of the calendar quarter of 6/30/2015).

A final Progress Report, final Federal Financial Report, and Final Invention Statement are required when an award ends.  All final reports are due within 90 days of the project period end date.  For further details regarding grant closeout requirements, refer to http://www.ahrq.gov/fund/closeout.htm.

The Federal Funding Accountability and Transparency Act of 2006 (Transparency Act), includes a requirement for awardees of Federal grants to report information about first-tier subawards and executive compensation under Federal assistance awards issued in FY2011 or later.  All awardees of applicable AHRQ grants and cooperative agreements are required to report to the Federal Subaward Reporting System (FSRS) available at www.fsrs.gov on all subawards over $25,000.  See the HHS Grants Policy Statement (http://www.ahrq.gov/fund/hhspolicy.htm) for additional information on this reporting requirement.

Section VII. Agency Contacts

We encourage inquiries concerning this funding opportunity and welcome the opportunity to answer questions from potential applicants.

Application Submission Contacts

eRA Service Desk (Questions regarding ASSIST, eRA Commons registration, submitting and tracking an application, documenting system problems that threaten submission by the due date, post submission issues)
Finding Help Online: http://grants.nih.gov/support/ (preferred method of contact)

Telephone: 301-402-7469 or 866-504-9552 (Toll Free)

Grants.gov Customer Support (Questions regarding Grants.gov registration and submission, downloading forms and application packages)
Contact Center Telephone: 800-518-4726

Web ticketing system: https://grants-portal.psc.gov/ContactUs.aspx
Email: support@grants.gov

Scientific/Research Contact(s)

Direct your questions about general FOA issues, including information on the inclusion of priority populations to:

Linda Franklin
Agency for Healthcare Research and Quality
Office of Extramural Research, Education and Priority Populations
Division of Scientific Review
Telephone: (301) 427-1904
E-mail: linda.franklin@ahrq.hhs.gov

Peer Review Contact(s)

Direct your questions about peer review issues of grant application made in response to this FOA to:

Linda Franklin
Agency for Healthcare Research and Quality
Office of Extramural Research, Education and Priority Populations
Division of Scientific Review
Telephone: (301) 427-1904
E-mail: linda.franklin@ahrq.hhs.gov

Financial/Grants Management Contact(s)

Direct your questions regarding fiscal matters to:

Brian Campbell
Office of Management Services
Grants Management
Agency for Healthcare Research and Quality
Telephone: (301) 427-1266
E-mail: brian.campbell@ahrq.hhs.gov

Section VIII. Other Information

Recently issued AHRQ policy notices may affect your application submission. A full list of policy notices published by AHRQ is provided in the NIH Guide for Grants and Contracts. Notices can also be found at AHRQ Grants Policy Notices.  All awards are subject to the terms and conditions, cost principles, and other considerations described in the HHS Grants Policy Statement.

Authority and Regulations

This program is described in the Catalog of Federal Domestic Assistance at http://www.cfda.gov/ and is not subject to the intergovernmental review requirements of Executive Order 12372 or Health Systems Agency review. Awards are made under the authority of 42 USC 299 et seq., and in accordance with 45 CFR Part 75 and other referenced applicable statutes and regulations.  All awards are subject to the terms and conditions, cost principles, and other considerations described in the HHS Grants Policy Statement. The HHS Grants Policy Statement can be found at http://www.ahrq.gov/fund/hhspolicy.htm.

NIH Office of Extramural Research Logo
Department of Health and Human Services (HHS) - Home Page
Department of Health
and Human Services (HHS)
USA.gov - Government Made Easy
NIH... Turning Discovery Into Health®


Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.